Yuan-Cheng Chen1,2,3, Jonathan Greenbaum2,3, Hui Shen2,3, Hong-Wen Deng1,2,3. 1. Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, PR China. 2. Center of Bioinformatics and Genomics, Tulane University, New Orleans, Louisiana 70112. 3. Department of Global Biostatistics and Data Science, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana 70112.
Abstract
Context: It has been well established that the human gut microbiome plays a critical role in the regulation of important biological processes and the mechanisms underlying numerous complex diseases. Although researchers have only recently begun to study the relationship between the gut microbiota and bone metabolism, early efforts have provided increased evidence to suggest an important association. Evidence Acquisition: In this study, we attempt to comprehensively summarize the relationship between the gut microbiota and bone metabolism by detailing the regulatory effects of the microbiome on various biological processes, including nutrient absorption and the intestinal mucosal barrier, immune system functionality, the gut-brain axis, and excretion of functional byproducts. In this review, we incorporate evidence from various types of studies, including observational, in vitro and in vivo animal experiments, as well as small efficacy clinic trails. Evidence Synthesis: We review the various potential mechanisms of influence for the gut microbiota on the regulation of bone metabolism and discuss the importance of further examining the potential effects of the gut microbiota on the risk of osteoporosis in humans. Furthermore, we outline some useful tools/approaches for metagenomics research and present some prominent examples of metagenomics association studies in humans. Conclusion: Current research efforts, although limited, clearly indicate that the gut microbiota may be implicated in bone metabolism, and therefore, further exploration of this relationship is a promising area of focus in bone health and osteoporosis research. Although most existing studies investigate this relationship using animal models, human studies are both needed and on the horizon.
Context: It has been well established that the humangut microbiome plays a critical role in the regulation of important biological processes and the mechanisms underlying numerous complex diseases. Although researchers have only recently begun to study the relationship between the gut microbiota and bone metabolism, early efforts have provided increased evidence to suggest an important association. Evidence Acquisition: In this study, we attempt to comprehensively summarize the relationship between the gut microbiota and bone metabolism by detailing the regulatory effects of the microbiome on various biological processes, including nutrient absorption and the intestinal mucosal barrier, immune system functionality, the gut-brain axis, and excretion of functional byproducts. In this review, we incorporate evidence from various types of studies, including observational, in vitro and in vivo animal experiments, as well as small efficacy clinic trails. Evidence Synthesis: We review the various potential mechanisms of influence for the gut microbiota on the regulation of bone metabolism and discuss the importance of further examining the potential effects of the gut microbiota on the risk of osteoporosis in humans. Furthermore, we outline some useful tools/approaches for metagenomics research and present some prominent examples of metagenomics association studies in humans. Conclusion: Current research efforts, although limited, clearly indicate that the gut microbiota may be implicated in bone metabolism, and therefore, further exploration of this relationship is a promising area of focus in bone health and osteoporosis research. Although most existing studies investigate this relationship using animal models, human studies are both needed and on the horizon.
Authors: Y Kadooka; M Sato; K Imaizumi; A Ogawa; K Ikuyama; Y Akai; M Okano; M Kagoshima; T Tsuchida Journal: Eur J Clin Nutr Date: 2010-03-10 Impact factor: 4.016
Authors: Julia K Goodrich; Jillian L Waters; Angela C Poole; Jessica L Sutter; Omry Koren; Ran Blekhman; Michelle Beaumont; William Van Treuren; Rob Knight; Jordana T Bell; Timothy D Spector; Andrew G Clark; Ruth E Ley Journal: Cell Date: 2014-11-06 Impact factor: 41.582
Authors: Valeria Rodríguez; María Rivoira; Ana Marchionatti; Adriana Pérez; Nori Tolosa de Talamoni Journal: Arch Biochem Biophys Date: 2013-10-03 Impact factor: 4.013
Authors: Jau-Yi Li; Benoit Chassaing; Abdul Malik Tyagi; Chiara Vaccaro; Tao Luo; Jonathan Adams; Trevor M Darby; M Neale Weitzmann; Jennifer G Mulle; Andrew T Gewirtz; Rheinallt M Jones; Roberto Pacifici Journal: J Clin Invest Date: 2016-04-25 Impact factor: 14.808
Authors: Karin C Wu; Sisi Cao; Connie M Weaver; Nicole J King; Sheena Patel; Hillary Kingman; Deborah E Sellmeyer; Kathryn McCauley; Danny Li; Susan V Lynch; Tiffany Y Kim; Dennis M Black; Martin M Shafer; Mustafa Özçam; Din L Lin; Stanley J Rogers; Lygia Stewart; Jonathan T Carter; Andrew M Posselt; Anne L Schafer Journal: J Clin Endocrinol Metab Date: 2022-03-24 Impact factor: 5.958
Authors: Tao Zhou; Dianjianyi Sun; Xiang Li; Yoriko Heianza; Meryl S LeBoff; George A Bray; Frank M Sacks; Lu Qi Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045